Kensey Nash Corporation http://www.alacrastore.com/company-snapshot/Kensey_Nash_Corporation-1092019 Thursday, August 21, 2008 5:48:50 PM 1092019 Kensey Nash Corporation en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/PRN-0005-27111776newstex/PRN-0005-27111776xml EXTON, Pa., Aug. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its fourth quarter and fiscal year ended June ##, #### at #:##...04000000040160000401600104016018040160488/2/2008 11:10:31 PM18000000180040001800800018020000PR Newswire USPRN-0005-27111776KENSEY NASH CORPJOSEPH W KAUFMANNKNSYNewsNewstexhttp://www.alacrastore.com/storecontent/bir/267764bir/267764normKensey Nash Corp.United StatesManufacturing: Bio-absorbable materials and medical devices for femoral arterial puncture, closure and revascularization.3841282133911232521117DGKNSY7/11/2008 6:18:21 AM267764Company Profiles & FinancialsGale Company ProfilesUS - In June ####, the board of Kensey Nash Corp, a manufacturer of proprietary biomaterial products, authorized the repurchase of up to $## mil of the company's common stock outstanding in open market or privately negotiated transactions.6/25/2008 3:03:48 PM490057490057490057490057Kensey Nash CorpKensey Nash CorpKensey Nash CorpKensey Nash Corphttp://www.alacrastore.com/storecontent/Thomson_M%26A/Kensey_Nash_Corp_buys_back_stock-1989616020sdc/19896160201989616020Copyright © 2008, Thomson Financial, All Rights ReservedNasdaqDrugsUnited StatesBiological products, except diagnostic substances2836PAPennsylvaniaPublicKNSY2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances3841:Surgical and medical instruments and apparatus8731:Commercial physical and biological research2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances3841:Surgical and medical instruments and apparatus8731:Commercial physical and biological researchNasdaqDrugsUnited StatesBiological products, except diagnostic substances2836PAPennsylvaniaPublicKNSY149669002Mnfr biomaterial prodMnfr biomaterial prodCashCash OnlyCommon Stock149669002Jun 25 200810.0400055.8560018.5690016.4440013.1510021.3000021.3360013.46800117.757000.285000.2930010.118000.330004.140005.6130074.798001.40000164.793000.000000.000000.000000.000000.000000.0000031 Mar 0830 Jun 0730 Jun 0630 Jun 0530 Jun 0430 Jun 031.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.00000Kensey Nash Corp, located inExton, Pennsylvania,manufactures proprietarybiomaterial products (VITOSSScaffold FOAM products) forthe orthopedics, cardiology,drug/biologics delivery andwound care markets, includingarterial revascularization andpuncture closure devices(Angio-Seal Vascular ClosureDevice). They also developcardiovascular medicaltechnology devices forarterial puncture closure. Thecompany was founded in 1984.Kensey Nash Corp, located in Exton, Pennsylvania,manufactures proprietary biomaterial products (VITOSSScaffold FOAM products) for the orthopedics, cardiology,drug/biologics delivery and wound care markets, includingarterial revascularization and puncture closure devices(Angio-Seal Vascular Closure Device). They also developcardiovascular medical technology devices for arterialpuncture closure. The company was founded in 1984.Kensey Nash Corp, located in Exton, Pennsylvania, manufactures proprietary biomaterial products (VITOSS Scaffold FOAM products) for the orthopedics, cardiology, drug/biologics delivery and wound care markets, including arterial revascularization and puncture closure devices (Angio-Seal Vascular Closure Device). They also develop cardiovascular medical technology devices for arterial puncture closure. The company was founded in 1984.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.00000Kensey Nash Corp, located inExton, Pennsylvania,manufactures proprietarybiomaterial products (VITOSSScaffold FOAM products) forthe orthopedics, cardiology,drug/biologics delivery andwound care markets, includingarterial revascularization andpuncture closure devices(Angio-Seal Vascular ClosureDevice). They also developcardiovascular medicaltechnology devices forarterial puncture closure. Thecompany was founded in 1984.Kensey Nash Corp, located in Exton, Pennsylvania,manufactures proprietary biomaterial products (VITOSSScaffold FOAM products) for the orthopedics, cardiology,drug/biologics delivery and wound care markets, includingarterial revascularization and puncture closure devices(Angio-Seal Vascular Closure Device). They also developcardiovascular medical technology devices for arterialpuncture closure. The company was founded in 1984.Kensey Nash Corp, located in Exton, Pennsylvania, manufactures proprietary biomaterial products (VITOSS Scaffold FOAM products) for the orthopedics, cardiology, drug/biologics delivery and wound care markets, including arterial revascularization and puncture closure devices (Angio-Seal Vascular Closure Device). They also develop cardiovascular medical technology devices for arterial puncture closure. The company was founded in 1984.0.000000.000000.0000011.54000NU.S. Dollar23 Jun 08Mon, 23 Jun 2008 00:00:00 ESTDate Announced: 06/23/2008Date Effective:BuybackNot Appl.0.000000.000000.000000.000000.000000.00000Price/Share0.0000010 U.S. Dollar10.000000.0000010 U.S. Dollar10.000000.000000.000000.000000.000000.0000010 U.S. Dollar1.00000N5.089000.000000.000000.000000.000000.0000010.0000010.000000.000000.000000.000000.000000.000002.917000.000000.000000.000000.000000.000000.000000.000004.263000.000000.000000.0000032.6600030.8000029.29000-12.135005.118000.218000.00000-47.69500-21.4050033.13300337.97700117.757009.1150011.65700-46.99500-19.810001.000002.000003.000004.000005.000006.000007.000008.000009.00000US - In June 2008, the boardof Kensey Nash Corp, amanufacturer of proprietarybiomaterial products,authorized the repurchase ofup to $10 mil of the company'scommon stock outstanding inopen market or privatelynegotiated transactions.US - In June 2008, the board of Kensey Nash Corp, a manufacturer of proprietary biomaterial products, authorized the repurchase of up to $10 mil of the company's common stock outstanding in open market or privately negotiated transactions.US - In June 2008, the board of Kensey Nash Corp, a manufacturer of proprietarybiomaterial products, authorized the repurchase of up to $10 mil of the company's commonstock outstanding in open market or privately negotiated transactions.US - In June 2008, the board of Kensey Nash Corp, a manufacturer of proprietary biomaterial products, authorized the repurchase of up to $10 mil of the company's common stock outstanding in openmarket or privately negotiated transactions.US - In June 2008, the board of Kensey Nash Corp, a manufacturer of proprietary biomaterial products, authorized the repurchase of up to$10 mil of the company's common stock outstanding in open market or privately negotiated transactions.Intended0.000000.000000.000000.0000010.0400018.5690016.4440013.1510021.3000021.3360013.46800117.7570010.118000.290000.300001.060001.060000.760000.33000117.75700123.64900113.19100103.8530094.4250079.550003.633003.7180012.9310012.951008.786004.140004.421004.5560018.0910018.0950011.336005.6130069.4940060.3970061.3760058.2150044.3520074.79800164.79300140.52500130.19100115.63700101.2340084.82200Status:IntendedUS-999.00000np0.07500-999.00000np-50.56600-20.975003.516006.4080011.88200117.7570010.2370013.452000.000000.000000.000002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances3841:Surgical and medical instruments and apparatus8731:Commercial physical and biological research149669002NasdaqUnited States2836PennsylvaniaPublicKNSY2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances3841:Surgical and medical instruments and apparatus8731:Commercial physical and biological research149669002NasdaqUnited States2836PennsylvaniaPublicKNSY10.0000010.0000010.000005.08900Deal InformationThomson Financial Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26166061newstex/PRN-0005-26166061xml EXTON, Pa., Jun. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Kensey Nash Corporation (Nasdaq: KNSY) today updated and expanded its previously announced revenue guidance for its fourth quarter and fiscal year ended June ##,...0400000004016000040160010401604804016018040160030401604704016009040020000400200113000000130010001300100213002000130020016/23/2008 9:10:10 AM18000000180080001800400018012000180200001800600018011000PR Newswire USPRN-0005-26166061KENSEY NASH CORPJOSEPH W KAUFMANNKNSYNewsNewstexUS - Spectranetics Corp definitively agreed to acquire the endovascular business of Kensey Nash Corp, a manufacturer of biomaterials products, for $## mil. The consideration was to consist of $## mil in cash and up to $## mil in profit-related payments. The transaction was subject to customary closing conditions.5/14/2008 1:46:02 PM84760C49005A84760C490057Spectranetics CorpKensey Nash Corp-Endovascular BusinessSpectranetics CorpKensey Nash Corphttp://www.alacrastore.com/storecontent/Thomson_M%26A/Spectranetics_Corp_acquires_Kensey_Nash_Corp_Endovascular_from_Kensey_Nash_Corp-1977199020sdc/19771990201977199020Copyright © 2008, Thomson Financial, All Rights ReservedNasdaqMeasuring, Medical, Photo Equipment; ClocksUnited StatesSurgical and medical instruments and apparatus3841COColoradoPublicSPNC3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical supplies3841:Surgical and medical instruments and apparatus3842:Orthopedic, prosthetic, and surgical suppliesDrugsUnited StatesBiological products, except diagnostic substances2836PAPennsylvaniaSubsidiary171057002Mnfr,whl excimer lasersMnfr biomaterials prodCashEarnoutAssets1010369001May 14 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.00000Spectranetics Corp, located inColorado Springs, Colorado,manufactures and wholesalesexcimer laser and laserablation systems for use inmultiple, minimally invasivecardiovascular procedures. Thecompany was founded in 1984.Spectranetics Corp, located in Colorado Springs, Colorado,manufactures and wholesales excimer laser and laser ablationsystems for use in multiple, minimally invasivecardiovascular procedures. The company was founded in 1984.Spectranetics Corp, located in Colorado Springs, Colorado, manufactures and wholesales excimer laser and laser ablation systems for use in multiple, minimally invasive cardiovascular procedures. The company was founded in 1984.1.000002.000003.000004.00000The endovascular business ofKensey Nash Corp, located inPennsylvania, manufacturesbiomaterials products.The endovascular business of Kensey Nash Corp, located inPennsylvania, manufactures biomaterials products.The endovascular business of Kensey Nash Corp, located in Pennsylvania, manufactures biomaterials products.0.000000.000000.000000.00000NU.S. Dollar13 May 08Tue, 13 May 2008 00:00:00 ESTDate Announced: 05/13/2008Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000024 U.S. Dollar24.000000.0000024 U.S. Dollar24.000000.000000.000000.000000.0000024.0000024 U.S. Dollar1.00000N12.338000.000000.000000.000000.000000.0000024.0000024.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.00000US - Spectranetics Corpdefinitively agreed to acquirethe endovascular business ofKensey Nash Corp, amanufacturer of biomaterialsproducts, for $24 mil. Theconsideration was to consistof $10 mil in cash and up to$14 mil in profit-relatedpayments. The transaction wassubject to customary closingconditions.US - Spectranetics Corp definitively agreed to acquire the endovascular business of Kensey Nash Corp, a manufacturer of biomaterials products, for $24 mil. The consideration was to consist of $10 mil in cash and up to $14 mil in profit-related payments. The transaction was subject to customary closing conditions.US - Spectranetics Corp definitively agreed to acquire the endovascular business of KenseyNash Corp, a manufacturer of biomaterials products, for $24 mil. The consideration was toconsist of $10 mil in cash and up to $14 mil in profit-related payments. The transactionwas subject to customary closing conditions.US - Spectranetics Corp definitively agreed to acquire the endovascular business of Kensey Nash Corp, a manufacturer of biomaterials products, for $24 mil. The consideration was to consist of $10 milin cash and up to $14 mil in profit-related payments. The transaction was subject to customary closing conditions.US - Spectranetics Corp definitively agreed to acquire the endovascular business of Kensey Nash Corp, a manufacturer of biomaterialsproducts, for $24 mil. The consideration was to consist of $10 mil in cash and up to $14 mil in profit-related payments. The transactionwas subject to customary closing conditions.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances3841:Surgical and medical instruments and apparatus8731:Commercial physical and biological research171057002NasdaqUnited States3841ColoradoPublicSPNC2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances3841:Surgical and medical instruments and apparatus8731:Commercial physical and biological research149669002NasdaqUnited States2836PennsylvaniaPublicKNSY24.0000024.0000024.0000012.33800Deal InformationThomson Financial Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/ccbn/T1850688ccbn/T1850688norm...Welcome to Kensey Nash announces sale of endovascular business and strategic partnership with Spectranetics. (OPERATOR INSTRUCTIONS). As a reminder, today's conference is being recorded. I would now like to turn the conference over to your host, Joseph Kaufmann. Please go ahead. ... 5/13/2008 12:16:00 PMKensey Nash Corporation54.0000FinalKensey Nash Corporation Announces Sale of Endovascular Business and Strategic Partnership With Spectranetics Conference Call TranscriptKNSY9:00am ETTranscriptT1850688Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1822839ccbn/T1822839norm...Ladies and gentlemen, thank you for standing by and welcome to the Kensey Nash Third Quarter Earnings Release conference call. At this time all lines are in a listen-only mode. Later there will be an opportunity for questions and instructions will be given at that time. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded. I will now turn the conference over to your host, President and CEO, Joe Kaufmann. Please go ahead, Sir. ... 4/29/2008 12:22:00 PMKensey Nash Corporation54.0000FinalQ3 2008 Kensey Nash Corporation Earnings Conference Call TranscriptKNSY9:00am ETTranscriptT1822839Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1735701ccbn/T1735701norm1/25/2008 10:12:00 AMKensey Nash Corporation54.0000FinalQ2 2008 Kensey Nash Corporation Earnings Conference Call TranscriptKNSY9:00am ET...Ladies and gentlemen, thank you for standing by. Welcome to the second-quarter earnings release conference call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session; instructions will be given at that time. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded. I would now like to turn the conference over to our host, Mr. Joe Kaufmann, President and CEO. Please go ahead. ... TranscriptT1735701Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1696453ccbn/T1696453norm12/31/2007 6:05:36 PMKensey Nash Corporation54.0000FinalKensey Nash Corporation at 19th Annual Piper Jaffray Health Care Conference TranscriptKNSY12:00pm ET...Okay, good afternoon everyone. It's my pleasure to introduce the next company on our schedule, which is Kensey Nash. From Kensey is CEO Joe Kaufmann here to present. Joe, please go ahead. ... TranscriptT1696453Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1648105ccbn/T1648105norm10/19/2007 10:12:00 AMKensey Nash Corporation54.0000FinalQ1 2008 Kensey Nash Corporation Earnings Conference Call TranscriptKNSY9:00am ET...Ladies and gentlemen, thank you for standing by. Welcome to the first quarter earnings release conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session. Instructions will be given at that time. (OPERATOR INSTRUCTIONS) . As a reminder, this conference is being recorded. I would now like to turn the conference over to our host, Joseph Kaufmann. Please go ... TranscriptT1648105Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/srp/23422srp/23422norm...Address:Marsh Creek Corporate Center, ## East Uwchlan Avenue, Exton, Pennsylvania ##### Incorporated:DelawareWeb Site: www.kenseynash.comSIC Classification: Surgical and Medical Instruments and Apparatus (####) Business Description: Kensey Nash Corporation is a leading medical technology company providing innovative solutions, via novel technologies, for a wide range of medical procedures. The company has expanded well beyond its beginnings in vascular puncture closure and today provides an extensive range of products into multiple medical markets, primarily cardiovascular, sports medicine and spine, amongst others. Indices:Russell ####, Russell ####, S&P ### ... 23422490057106KNSY10/6/2006 12:37:00 PM23422Credit & Investment ResearchSharkRepellent.net